Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

× No keyword cloud information.

19 in total

1. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.

Authors: A CARLSSON; M LINDQVIST
Journal: Acta Physiol Scand Date: 1962-01

2. A rapid and sensitive method of quantitative determination of apomorphine.

Authors: P N KAUL; E BROCHMANN-HANSSEN; E L WAY
Journal: J Am Pharm Assoc Am Pharm Assoc Date: 1959-11

3. The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors: H BLASCHKO; T L CHRUSCIEL
Journal: J Physiol Date: 1960-05 Impact factor: 5.182

4. Evidence for a central noradrenaline receptor stimulation by clonidine.

Authors: N E Andén; H Corrodi; K Fuxe; B Hökfelt; T Hökfelt; C Rydin; T Svensson
Journal: Life Sci Date: 1970-05-01 Impact factor: 5.037

5. Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.

Authors: G Bartholini; A Pletscher
Journal: J Pharm Pharmacol Date: 1969-05 Impact factor: 3.765

6. Peripheral factors in the mediation of the effects of L-dopa on locomotor activity.

Authors: L L Butcher; J Engel
Journal: J Pharm Pharmacol Date: 1969-09 Impact factor: 3.765

7. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.

Authors: G Bartholini; J E Blum; A Pletscher
Journal: J Pharm Pharmacol Date: 1969-05 Impact factor: 3.765

8. Evidence for dopamine receptor stimulation by apomorphine.

Authors: N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal: J Pharm Pharmacol Date: 1967-09 Impact factor: 3.765

9. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.

Authors: N J Uretsky; L S Seiden
Journal: J Pharmacol Exp Ther Date: 1969-07 Impact factor: 4.030

10. A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors: A CARLSSON; B WALDECK
Journal: Acta Physiol Scand Date: 1958-12-15

49 in total

1. Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine.

Authors: G Engström; U Strömbom; T H Svensson; B Waldeck
Journal: J Neural Transm Date: 1975 Impact factor: 3.575

2. Dopamine synthesis in the nigrostriatal system at the presymptomatic and early symptomatic stages in parkinsonian mice.

Authors: G R Khakimova; E A Kozina; A Ya Sapronova; M V Ugrumov
Journal: Dokl Biol Sci Date: 2011-12-02

Review 3. Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Authors: Eric A Stone; David Quartermain
Journal: Psychopharmacology (Berl) Date: 2005-01-12 Impact factor: 4.530

4. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.

Authors: K Modigh
Journal: J Neural Transm Date: 1975 Impact factor: 3.575

5. On the mode of action of clonidine: relationship between effects on behaviour and cyclic nucleotide content in mouse brain.

Authors: S W Gumulka; V Dinnendahl; D Bartmus; P S Schönhöfer; K Stock
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-05 Impact factor: 3.000

6. Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission.

Authors: T H Svensson; U Strömbom
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-08 Impact factor: 3.000

7. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.

Authors: S B Ross; D M Jackson; E M Wallis; S R Edwards
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-05 Impact factor: 3.000

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.